Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms

被引:15
作者
Bartolazzi, A [1 ]
Bussolati, G
机构
[1] St Andrea Univ Hosp, Dept Pathol, Rome, Italy
[2] Univ Turin, Dept Pathol, Turin, Italy
关键词
D O I
10.1111/j.1365-2559.2005.02214.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:212 / 213
页数:3
相关论文
共 4 条
[1]   Methodological considerations regarding the use of galectin-3 expression analysis in preoperative evaluation of thyroid nodules [J].
Bartolazzi, A ;
Papotti, M ;
Orlandi, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02) :950-950
[2]   Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry [J].
Bussolati, G ;
Gugliotta, P ;
Volante, M ;
Pace, M ;
Papotti, M .
HISTOPATHOLOGY, 1997, 31 (05) :400-407
[3]  
Herrmann ME, 2002, ARCH PATHOL LAB MED, V126, P710
[4]   Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms [J].
Mehrotra, P ;
Okpokam, A ;
Bouhaidar, R ;
Johnson, SJ ;
Wilson, JA ;
Davies, BR ;
Lennard, TWJ .
HISTOPATHOLOGY, 2004, 45 (05) :493-500